Differences in the Gut Microbiome of Women With and Without Hypoactive Sexual Desire Disorder: Case Control Study (Preprint)

Author:

Li GuanjianORCID,Li WeiranORCID,Song BingORCID,Wang ChaoORCID,Shen QunshanORCID,Li BoORCID,Tang DongdongORCID,Xu ChuanORCID,Geng HaoORCID,Gao YangORCID,Wang GuanxiongORCID,Wu HuanORCID,Zhang ZhiguoORCID,Xu XiaofengORCID,Zhou PingORCID,Wei ZhaolianORCID,He XiaojinORCID,Cao YunxiaORCID

Abstract

BACKGROUND

The gut microbiome is receiving considerable attention as a potentially modifiable risk factor and therapeutic target for numerous mental and neurological diseases.

OBJECTIVE

This study aimed to explore and assess the difference in the composition of gut microbes and fecal metabolites between women with hypoactive sexual desire disorder (HSDD) and healthy controls.

METHODS

We employed an online recruitment method to enroll “hard-to-reach” HSDD populations. After a stringent diagnostic and exclusion process based on DSM-IV criteria, fecal samples collected from 24 women with HSDD and 22 age-matched, healthy controls underwent microbiome analysis using 16S ribosomal RNA gene sequencing and metabolome analysis using untargeted liquid chromatography–mass spectrometry.

RESULTS

We found a decreased abundance of <i>Ruminococcaceae</i> and increased abundance of <i>Bifidobacterium</i> and <i>Lactobacillus</i> among women with HSDD. Fecal samples from women with HSDD showed significantly altered metabolic signatures compared with healthy controls. The abundance of <i>Bifidobacterium</i>, <i>Lactobacillus</i>, and several fecal metabolites correlated negatively with the sexual desire score, while the number of <i>Ruminococcaceae</i> correlated positively with the sexual desire score in all subjects.

CONCLUSIONS

Our analysis of fecal samples from women with HSDD and healthy controls identified significantly different gut microbes and metabolic signatures. These preliminary findings could be useful for developing strategies to adjust the level of human sexual desire by modifying gut microbiota.

CLINICALTRIAL

Chinese Clinical Trial Registry ChiCTR1800020321; http://www.chictr.org.cn/showproj.aspx?proj=34267

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3